Alberta will investigate the effectiveness of a drug touted by U.S. President Donald Trump in preventing hospitalization for people at the highest risk of developing severe symptoms of COVID-19. The Alberta Hope COVID-19 study will recruit 1,600 Albertans to determine whether a prescribed five-day treatment of hydroxychloroquine (HCQ) can prevent hospitalization for those at highest risk of developing a severe illness. Health Minister Tyler Shandro says the goal is to reduce the risk of severe disease experienced by individuals and reduce the burden on the health-care system by helping people recover from the effects of the virus at home. “As...